1[1]Bridonneau P,Marcilly H,Vernois-Martin M,et al.Li quid pasteurization of an immunoglobulin preparations without stabilizer:effects on its biologica l and biochemical properties.Vox Sang,1996,70:203
2[2]Barandun S,Kistler P,Jeunet F,et al.Intravenous administrati on of human γ globulin.Vox Sang,1962,7:157
3[3]Alving BM,Hojima Y,Pisano JJ,et al.Hypotension associated with p rekallikrein activator(Hageman factor fragments)in plasma protein fraction .N Engl Med,1978,299:66
4[4]Yang YHJ,Catherine N,Jehwee NY,et al.Antibody Fc f unctio nal activity of intravenous immunoglobulin preparations treated with sol vent-detergent for virus inactivation.Vox Sang,1994,67:337
5[5]Yasuda H,Yajima T,Tanii T,et al.Opsonic and complement-depend ent bacteric idal activities of various immunoglobulin preparations for intravenous use.Vox Sang,1986,51:270
6[6]van Furth R,Leijh PCJ,Klein F.Correlation between opsonic activi t y for various microorganisms and composition of gamma globulin preparati ons for intravenous use.Infect Dis,1984,149(4):511
7[7]Horwitz MZ,Silverstein SC.Influence of the Escherichiacoli caps ule on complement fixation and on phagocytosis and killing by human p hagocytes.J Clin Invest,1980,65:82
8[8]Jungi TW,Santer M,Lerch PG,et al.Effect of various treatments of gamma- globulin(IgG)for achieving intravenous tolerance on the capacity to inte ract with human monocyte Fc receptors.Vox Sang,1986,51:18
9[9]Klaesson S,Ringden O,Markling L,et al.Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.Scand J Immunol,1993,38:477
10[10]Nachbaur D,Herold M,Eibl B,et al.A comparative study of the in vitr o immunomodulatory activity of human intact immunoglobulin(7S IVIG),F(ab) 2 fragments(5S IVIG)and Fc fragments.Immunology,1997,90:212
